{
    "2018-11-15": [
        [
            {
                "time": "2018-11-15",
                "original_text": "After Hours Most Active for Nov 15, 2018: QQQ, T, MSFT, GE, INTC, NVDA, ABBV, DWDP, HAL, FCX, CSCO, AMD",
                "features": {
                    "keywords": [
                        "Most Active",
                        "ABBV",
                        "MSFT",
                        "GE"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "technology",
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-11-15",
                "original_text": "ABBVIE LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 in AbbVie, Inc. to Contact the Firm",
                "features": {
                    "keywords": [
                        "ABBV",
                        "Losses",
                        "Investors",
                        "Legal Action"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-11-15",
                "original_text": "Exploring Clovis Oncology’s Operational Performance",
                "features": {
                    "keywords": [
                        "Clovis Oncology",
                        "Operational Performance"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-11-15",
                "original_text": "Understanding Clovis Oncology’s Gross Margin Trend",
                "features": {
                    "keywords": [
                        "Clovis Oncology",
                        "Gross Margin",
                        "Trend"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-11-15",
                "original_text": "The Daily Biotech Pulse: FDA Nod For Mallinckrodt's Pain Drug, AbbVie-Neurocrine Report Positive Elagolix Results",
                "features": {
                    "keywords": [
                        "FDA",
                        "Mallinckrodt",
                        "Pain Drug",
                        "Elagolix",
                        "Positive Results"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-11-15",
                "original_text": "AbbVie (ABBV) Gains As Market Dips: What You Should Know",
                "features": {
                    "keywords": [
                        "ABBV",
                        "Gains",
                        "Market Dips"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-11-15",
                "original_text": "SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AbbVie Inc. of Class Action Lawsuit and Upcoming Deadline – ABBV",
                "features": {
                    "keywords": [
                        "ABBV",
                        "Shareholder Losses",
                        "Class Action",
                        "Lawsuit"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}